Dr Leonard I Japko, MD | |
4755 Ogletown Stanton Road, Newark, DE 19718-0001 | |
(302) 454-9830 | |
(302) 454-1445 |
Full Name | Dr Leonard I Japko |
---|---|
Gender | Male |
Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
Location | 4755 Ogletown Stanton Road, Newark, Delaware |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1851397392 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | C10003770 (Delaware) | Primary |
Entity Name | Prospect Health Access Network Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
A study of older adults with diabetes mellitus (DM) suggests a bidirectional association between hypoglycemic (low blood glucose) events and dementia, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Proposed changes to payments for evaluation and management codes do not appropriately recognize the value of cognitive care required to treat complex patients, and the proposal should not be implemented, says the American College of Physicians.
Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates (NEA), one of the world's leading venture capital firms. The capital will be used to continue to rapidly progress Zyngenia's pipeline of Zybodies™, which are novel, multi-specific, antibody-based molecules that address two or more biological targets with a single protein drug.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Leonard I Japko, MD Po Box 12210, Wilmington, DE 19850-2210 Ph: (302) 454-9830 | Dr Leonard I Japko, MD 4755 Ogletown Stanton Road, Newark, DE 19718-0001 Ph: (302) 454-9830 |
News Archive
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
A study of older adults with diabetes mellitus (DM) suggests a bidirectional association between hypoglycemic (low blood glucose) events and dementia, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Proposed changes to payments for evaluation and management codes do not appropriately recognize the value of cognitive care required to treat complex patients, and the proposal should not be implemented, says the American College of Physicians.
Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, announced today the completion of a $15 million Series A financing extension from New Enterprise Associates (NEA), one of the world's leading venture capital firms. The capital will be used to continue to rapidly progress Zyngenia's pipeline of Zybodies™, which are novel, multi-specific, antibody-based molecules that address two or more biological targets with a single protein drug.
› Verified 1 days ago
Dr. Brian W. Little, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4755 Ogletown Stanton Rd, Office Of Academic Affairs & Research, Newark, DE 19718 Phone: 302-733-1042 Fax: 302-733-1068 | |
Dr. Steven Todd Kramer, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-3630 Fax: 302-733-3686 | |
Dr. Michael Douglas Kanzer, MD Pathology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-454-9830 Fax: 302-454-1445 | |
Dr. William Macleod Kirby, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-454-9830 Fax: 302-454-1445 | |
Dr. Cynthia Ellen Flynn, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-454-9830 Fax: 302-454-1445 | |
Christine Elizabeth Burgert-lon, DO Pathology Medicare: Accepting Medicare Assignments Practice Location: 4701 Ogletown Stanton Rd Ste 4200, Newark, DE 19713 Phone: 302-737-7700 Fax: 302-737-5407 | |
Dr. Gary Bruce Witkin, MD Pathology Medicare: Medicare Enrolled Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-454-9830 Fax: 302-454-1445 |